Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Biomedicines|July 28, 2026
Novel Radiotherapy Delivery Modalities and Their Potential to Synergize with ImmunotherapyIvaylo B Mihaylov, Benjamin SpielerBiomedicines|October 29, 2025
Preclinical Tumor Growth Delay Is More Reliable from Imaging-Based Rather than Manual Caliper Volume MeasurementsIfeanyichukwu Ogobuiro, Benjamin Spieler, Ivaylo B MihaylovFrontiers in Oncology|May 14, 2023
Abscopal effect observed in visceral and osseous metastases after liver SBRT in combination with nivolumab and relatlimab for sinonasal mucosal melanoma-a case reportDanielle Cerbon, Karen Moya-Brown, Ivaylo B Mihaylov, et al.Biomedicines|May 28, 2022
Lung Inflammation Predictors in Combined Immune Checkpoint-Inhibitor and Radiation Therapy-Proof-of-Concept Animal StudyBenjamin Spieler, Teresa M Giret, Scott Welford, et al.Plos One|August 24, 2021
Toward prediction of abscopal effect in radioimmunotherapy: Pre-clinical investigationIvaylo B Mihaylov, Tulasigeri M Totiger, Teresa M Giret, et al.Journal of Medical Radiation Sciences|August 12, 2016
Transperineal implantation of gold fiducial markers (gold seeds) for prostate image-guided radiation therapy: a feasible technique associated with a low risk of complicationsAkram Saad, Jeffrey Goldstein, Yaacov Richard Lawrence, et al.Practical Radiation Oncology|November 30, 2019
Advantages of Radiation Therapy Simulation with 0.35 Tesla Magnetic Resonance Imaging for Stereotactic Ablation of Spinal MetastasesBenjamin Spieler, Stuart E Samuels, Ricardo Llorente, et al.The Oncologist|January 23, 2025
Is it time to retire preoperative radiation for localized esophageal and gastro-esophageal adenocarcinoma?Cindy M Pabon, Benjamin Spieler, Jenny J Li, et al.Scientific Reports|November 4, 2022
MRI-based delta-radiomic features for prediction of local control in liver lesions treated with stereotactic body radiation therapyWill H Jin, Garrett N Simpson, Nesrin Dogan, et al.Frontiers in Oncology|November 30, 2023
Predicting response to immunotherapy in non-small cell lung cancer- from bench to bedsideChris Montoya, Benjamin Spieler, Scott M Welford, et al.Pageof 3